Effect of etelcalcetide versus alfacalcidol on left ventricular function and feature-tracking cardiac magnetic resonance imaging in hemodialysis —a post-hoc analysis of a randomized, controlled trial
Calcimimetic therapy with etelcalcetide (ETEL) has been shown to attenuate the advancement of left ventricular (LV) hypertrophy in hemodialysis patients measured by cardiac magnetic resonance (CMR). The aim of...
Source: Journal of Cardiovascular Magnetic Resonance - Category: Radiology Authors: Katharina D örr, Andreas Kammerlander, Francesco Lauriero, Matthias Lorenz, Rodrig Marculescu and Dietrich Beitzke Tags: Research Source Type: research
More News: Cardiology | Cardiovascular | Dialysis | Heart | Hemodialysis | MRI Scan | Nutrition | Radiology